Company intelligence / Profile preview

Constitutional Medical Investors

Marlborough, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Constitutional Medical (CMI) was a medical diagnostics company focused on developing innovative systems for hematology testing. The company's primary technology was a high-speed, automated blood analysis platform designed to improve the efficiency and accuracy of laboratory workflows. CMI was founded by a team of experienced diagnostics executives and was backed by private equity before being acquired by Roche to bolster its laboratory diagnostics portfolio. The acquisition integrated CMI's proprietary hematology solutions into Roche's global diagnostic offerings.

Therapeutic areas: Hematology
Modalities: DeviceDiagnostic System
Industry: Pathology

Beyond the preview

Go deeper on Constitutional Medical Investors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Constitutional Medical Investors.

Explore the full profile